Israel - English - Ministry of Health

gilead sciences israel ltd - sofosbuvir; velpatasvir; voxilaprevir - film coated tablets - voxilaprevir 100 mg; velpatasvir 100 mg; sofosbuvir 400 mg - sofosbuvir, velpatasvir and voxilaprevir - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.

Singapore - English - HSA (Health Sciences Authority)

gilead sciences singapore pte. ltd. - sofosbuvir; velpatasvir; voxilaprevir - tablet, film coated - sofosbuvir 400 mg; velpatasvir 100 mg; voxilaprevir 100 mg

Canada - English - Health Canada

gilead sciences canada inc - sofosbuvir; velpatasvir; voxilaprevir - tablet - 400mg; 100mg; 100mg - sofosbuvir 400mg; velpatasvir 100mg; voxilaprevir 100mg - hcv polymerase inhibitors

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gilead sciences international ltd - voxilaprevir; velpatasvir; sofosbuvir - tablet - 100mg ; 100mg ; 400mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

gilead sciences ireland uc, ireland - sofosbuvir,velpatasvir,voxilaprevir - film-coated tablet - 400,100,100 mg,

New Zealand - English - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - sofosbuvir 400mg;  ;  ;  ; velpatasvir 100mg;  ;  ;  ; voxilaprevir 100mg;   - film coated tablet - active: sofosbuvir 400mg       velpatasvir 100mg       voxilaprevir 100mg   excipient: colloidal silicon dioxide copovidone croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry beige 85f170040 - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.